Donald Trump, NIH
1don MSN
A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...
Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...
Biotech startups generally rely on small business innovation grants to develop their technology. The Trump administration's ...
As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...
Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...
Chrystal Starbird, a cancer researcher at the University of North Carolina School of Medicine, had been preparing to serve on ...
The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...
The Recount (Video) on MSN13h
"Safety issues": RFK Jr. says he would direct NIH and FDA to review the safety of medical abortion drug mifepristone."We need to know what adverse events are. We need to understand the safety of every drug, mifepristone, and every other drug.
President Donald Trump's nominee for HHS Secretary, RFK Jr., navigated questions on abortion, vaccines, and social welfare as he hopes to secure Senate support.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback